These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 35181473)

  • 1. Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis.
    Mughees M; Kaushal JB; Sharma G; Wajid S; Batra SK; Siddiqui JA
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):497-512. PubMed ID: 35181473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management.
    Ullah A; Jiao W; Shen B
    Cell Mol Biol Lett; 2024 May; 29(1):73. PubMed ID: 38745115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer.
    Song N; Cui K; Zeng L; Li M; Fan Y; Shi P; Wang Z; Su W; Wang H
    Eur J Pharmacol; 2024 Mar; 967():176357. PubMed ID: 38309677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis.
    Adekoya TO; Richardson RM
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.
    Bhat AA; Nisar S; Singh M; Ashraf B; Masoodi T; Prasad CP; Sharma A; Maacha S; Karedath T; Hashem S; Yasin SB; Bagga P; Reddy R; Frennaux MP; Uddin S; Dhawan P; Haris M; Macha MA
    Cancer Commun (Lond); 2022 Aug; 42(8):689-715. PubMed ID: 35791509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles of chemokines in prostate cancer.
    Vindrieux D; Escobar P; Lazennec G
    Endocr Relat Cancer; 2009 Sep; 16(3):663-73. PubMed ID: 19556286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy.
    Bhat AA; Nisar S; Maacha S; Carneiro-Lobo TC; Akhtar S; Siveen KS; Wani NA; Rizwan A; Bagga P; Singh M; Reddy R; Uddin S; Grivel JC; Chand G; Frenneaux MP; Siddiqi MA; Bedognetti D; El-Rifai W; Macha MA; Haris M
    Mol Cancer; 2021 Jan; 20(1):2. PubMed ID: 33390169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies.
    Baci D; Bruno A; Cascini C; Gallazzi M; Mortara L; Sessa F; Pelosi G; Albini A; Noonan DM
    J Exp Clin Cancer Res; 2019 Nov; 38(1):464. PubMed ID: 31718684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MT1G, an emerging ferroptosis-related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer.
    Cheng B; Lai Y; Huang H; Peng S; Tang C; Chen J; Luo T; Wu J; He H; Wang Q; Huang H
    Environ Toxicol; 2024 Feb; 39(2):927-941. PubMed ID: 37972062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy.
    Bule P; Aguiar SI; Aires-Da-Silva F; Dias JNR
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic/biologic mechanism of racial disparity: Update.
    Powell IJ; Chinni SR; Reddy SS; Zaslavsky A; Gavande N
    Urol Oncol; 2021 Jan; 39(1):34-40. PubMed ID: 32900629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins.
    Nasser MW; Elbaz M; Ahirwar DK; Ganju RK
    Cancer Lett; 2015 Aug; 365(1):11-22. PubMed ID: 25963887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Challenges and Emerging Opportunities of Targeting Cytokines and Chemokine-Driven Inflammatory Signals in Metastatic Castrate-Resistant Prostate Cancer.
    Waugh DJJ; McGovern JA; McCusker S
    Crit Rev Oncog; 2022; 27(1):25-43. PubMed ID: 35993977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of chemokine signaling with non-coding RNAs in tumor microenvironment and heterogeneity in different cancers.
    Arora S; Khan S; Zaki A; Tabassum G; Mohsin M; Bhutto HN; Ahmad T; Fatma T; Syed MA
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):720-736. PubMed ID: 35257861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokines and receptors in the development and progression of malignant tumors.
    Zhao HQ; Jiang J
    Cytokine; 2023 Oct; 170():156335. PubMed ID: 37591136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifaceted role of chemokines in solid tumors: From biology to therapy.
    Raza S; Rajak S; Tewari A; Gupta P; Chattopadhyay N; Sinha RA; Chakravarti B
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):1105-1121. PubMed ID: 34979274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling.
    Xie T; Fu DJ; Li ZM; Lv DJ; Song XL; Yu YZ; Wang C; Li KJ; Zhai B; Wu J; Feng NH; Zhao SC
    Mol Cancer; 2022 Sep; 21(1):173. PubMed ID: 36045408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in landscape and related therapeutic targets of the prostate tumor microenvironment.
    Li D; Xu W; Chang Y; Xiao Y; He Y; Ren S
    Acta Biochim Biophys Sin (Shanghai); 2023 Jun; 55(6):956-973. PubMed ID: 37294106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icariin inhibits prostate cancer bone metastasis and destruction via suppressing TAM/CCL5-mediated osteoclastogenesis.
    Chen C; Wang S; Wang N; Zheng Y; Zhou J; Hong M; Chen Z; Wang S; Wang Z; Xiang S
    Phytomedicine; 2023 Nov; 120():155076. PubMed ID: 37716031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancer.
    Miro C; Di Giovanni A; Murolo M; Cicatiello AG; Nappi A; Sagliocchi S; Di Cicco E; Morra F; Celetti A; Pacifico F; Imbimbo C; Crocetto F; Dentice M
    Cancer Lett; 2022 Apr; 532():215581. PubMed ID: 35134514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.